过敏性鼻炎的局部药物治疗：奈多罗米
Topical pharmacotherapy for allergic rhinitis: nedocromil.
作者信息
Mabry R L
机构信息
Department of Otolaryngology, University of Texas Southwestern Medical Center, Dallas 75235-9035.
出版信息
Am J Otolaryngol. 1993 Nov-Dec;14(6):379-81. doi: 10.1016/0196-0709(93)90110-s.
Nedocromil sodium is a mast-cell stabilizer that prevents or ablates both the acute and late phases of the allergic response. It is an antiinflammatory agent that is not a steroid. It is more potent than the currently available mast-cell stabilizer, cromolyn, and maintenance therapy may be possible at less frequent intervals than the initially recommended regimen of 4 times daily. Nedocromil for pulmonary administration is currently available. The nasal form has undergone clinical trials but has not yet been released in the United States.
奈多罗米钠是一种肥大细胞稳定剂，可预防或消除过敏反应的急性期和晚期。它是一种非类固醇的抗炎药。它比目前可用的肥大细胞稳定剂色甘酸钠更有效，维持治疗的给药间隔可能比最初推荐的每日4次的方案更不频繁。目前有用于肺部给药的奈多罗米。鼻用剂型已进行临床试验，但尚未在美国上市。
Zotero 插件